Form 4 for MBIO MUSTANG BIO, INC.
Accepted 2026-01-05 00:00:00 ET · period of report 2026-01-02 · accession 0001429260-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-05 | 2026-01-02 | MBIO | Fortress Biotech, Inc. | 10% | A - Grant | $0.00 | +278.4K | 536.6K | +108% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | COMMON STOCK, PAR VALUE $0.0001 | 2026-01-02 | A | A | 278,385 | $0.00 | 536,577 | D | — | — | (F1) The Reporting Person is entitled to an annual dividend on its Class A Preferred Stock equal to 2.5% of the Issuer's fully diluted outstanding capitalization on December 31. 278,385 shares were granted by the Issuer to the Reporting person for the 2025 annual dividend. |